NVO Novo Nordisk

132.50

4.19 (3.27%)

02 May 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type
Novo Nordisk	NYSE:NVO	NYSE	Common Stock

	Price Change	% Change	Share Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	4.19	3.27%	132.50	130.13	127.50	127.80	5,217,690	01:00:00

Notice of Iran-related Disclosure Filed Pursuant to Section 13(r)(3) of the Exchange Act (irannotice)

04/02/2019 6:44pm

Edgar (US Regulatory)

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

February 4, 2019

Re: Notice of disclosure filed in Exchange Act Annual Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act

Dear Sirs,

Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended, notice is hereby provided that Novo Nordisk A/S has made disclosure pursuant to those provisions in its Annual Report on Form 20-F for the year ended December 31, 2018, which was filed with the Securities and Exchange Commission on February 4, 2019.

Sincerely,



/s/ Lars Fruergaard Jørgensen		/s/ Karsten Munk Knudsen
Lars Fruergaard Jørgensen President and Chief Executive Officer		Karsten Munk Knudsen Executive Vice President and Chief Financial Officer